Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Clin Oncol. Jun 24, 2025; 16(6): 108393
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.108393
Figure 1
Figure 1 Overall ovarian carcinoma-related age-adjusted mortality rates per 100000 in the United States, 1999 to 2020. aP value < 0.05, statistically significant annual percent change values. APC: Annual percent change; CI: Confidence interval.
Figure 2
Figure 2 Ovarian carcinoma-related age-adjusted mortality rates per 1000000, stratified by age groups in the United States, 1999 to 2020. aP value < 0.05, statistically significant annual percent change values. APC: Annual percent change; CI: Confidence interval.
Figure 3
Figure 3 Ovarian carcinoma-related age-adjusted mortality rates per 100000, stratified by race in the United States, 1999 to 2020. aP value < 0.05, statistically significant annual percent change values. NH: Non-Hispanic; APC: Annual percent change; CI: Confidence interval.
Figure 4
Figure 4 Ovarian carcinoma-related age-adjusted mortality rates per 1000000, stratified by urbanization group in the United States, 1999 to 2020. aP value < 0.05, statistically significant annual percent change values. APC: Annual percent change; CI: Confidence interval.
Figure 5
Figure 5 Ovarian carcinoma-related age-adjusted mortality rates per 100000, stratified by census regions, in the United States, 1999 to 2020. aP value < 0.05, statistically significant annual percent change values. APC: Annual percent change; CI: Confidence interval.
Figure 6
Figure 6 Ovarian carcinoma-related age-adjusted mortality rates per 100000, stratified by states, in the United States, 1999 to 2020.